Checkpoint inhibitor therapy in immunosuppressed patients with Merkel cell carcinoma: not all immunosuppression is created equal.
作者信息
Brohl Andrew S
机构信息
Sarcoma Department and Department of Cutaneous Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
出版信息
BMJ Oncol. 2025 Mar 6;4(1):e000695. doi: 10.1136/bmjonc-2024-000695. eCollection 2025.
Abstract
摘要
相似文献
1
Checkpoint inhibitor therapy in immunosuppressed patients with Merkel cell carcinoma: not all immunosuppression is created equal.免疫抑制的默克尔细胞癌患者的检查点抑制剂疗法：并非所有免疫抑制情况都是相同的。
BMJ Oncol. 2025 Mar 6;4(1):e000695. doi: 10.1136/bmjonc-2024-000695. eCollection 2025.
2
Immunotherapy response in immunosuppressed patients with Merkel cell carcinoma: analysis of 183 patients.免疫抑制的默克尔细胞癌患者的免疫治疗反应：183例患者的分析
BMJ Oncol. 2025 Mar 6;4(1):e000654. doi: 10.1136/bmjonc-2024-000654. eCollection 2025.
3
The treatment of Merkel cell carcinoma with immune checkpoint inhibitors: implications for patients with rheumatoid arthritis.免疫检查点抑制剂治疗默克尔细胞癌：对类风湿性关节炎患者的影响。
Rheumatol Adv Pract. 2021 Sep 28;5(3):rkab037. doi: 10.1093/rap/rkab037. eCollection 2021.
4
[Personalized medicine in the treatment of periocular tumors : Targeted treatment and use of immune checkpoint inhibitors].[个性化医疗在眼周肿瘤治疗中的应用：靶向治疗与免疫检查点抑制剂的使用]
Ophthalmologe. 2020 Jun;117(6):521-527. doi: 10.1007/s00347-019-01034-z.
5
Differential Outcomes Among Immunosuppressed Patients With Merkel Cell Carcinoma: Impact of Immunosuppression Type on Cancer-specific and Overall Survival.免疫抑制型 Merkel 细胞癌患者的不同结局：免疫抑制类型对癌症特异性和总体生存率的影响。
Am J Clin Oncol. 2019 Jan;42(1):82-88. doi: 10.1097/COC.0000000000000482.
6
Immune Checkpoint Inhibition in Non-Melanoma Skin Cancer: A Review of Current Evidence.非黑色素瘤皮肤癌中的免疫检查点抑制：当前证据综述
Front Oncol. 2021 Dec 20;11:734354. doi: 10.3389/fonc.2021.734354. eCollection 2021.
7
Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma.最近默克尔细胞癌患者的治疗进展和治疗模式的改变。
Oncologist. 2019 Oct;24(10):1375-1383. doi: 10.1634/theoncologist.2018-0718. Epub 2019 Apr 8.
8
Cytokines, Chemokines, and Other Biomarkers of Response for Checkpoint Inhibitor Therapy in Skin Cancer.皮肤癌中检查点抑制剂治疗反应的细胞因子、趋化因子及其他生物标志物
Front Med (Lausanne). 2018 Dec 12;5:351. doi: 10.3389/fmed.2018.00351. eCollection 2018.
9
Cutaneous Oncology in the Immunosuppressed.免疫抑制患者的皮肤肿瘤学
Dermatol Clin. 2023 Jan;41(1):141-162. doi: 10.1016/j.det.2022.07.012.
10
Decreased survival and increased recurrence in Merkel cell carcinoma significantly linked with immunosuppression.默克尔细胞癌患者生存率降低及复发率增加与免疫抑制显著相关。
J Surg Oncol. 2020 Sep;122(4):653-659. doi: 10.1002/jso.26048. Epub 2020 Jun 20.
本文引用的文献
1
A systematic review and meta-analysis of observational studies and uncontrolled trials reporting on the use of checkpoint blockers in patients with cancer and pre-existing autoimmune disease.一项系统性综述和荟萃分析，观察性研究和非对照试验报告了在患有癌症和预先存在的自身免疫性疾病的患者中使用检查点抑制剂的情况。
Eur J Cancer. 2024 Aug;207:114148. doi: 10.1016/j.ejca.2024.114148. Epub 2024 May 31.
2
First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 study.在转移性 Merkel 细胞癌患者中进行一线avelumab 治疗：JAVELIN Merkel 200 研究 B 部分的 4 年随访结果。
ESMO Open. 2024 May;9(5):103461. doi: 10.1016/j.esmoop.2024.103461. Epub 2024 May 13.
3
Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia.免疫检查点抑制剂治疗合并慢性淋巴细胞白血病的晚期黑色素瘤患者的疗效。
Ann Oncol. 2023 Sep;34(9):796-805. doi: 10.1016/j.annonc.2023.06.007. Epub 2023 Jul 4.
4
Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma.接受一线帕博利珠单抗治疗的晚期 Merkel 细胞癌患者的 3 年生存率、相关因素和挽救治疗。
J Immunother Cancer. 2021 Apr;9(4). doi: 10.1136/jitc-2021-002478.
5
The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy.默克尔细胞癌的基因组特征及免疫检查点抑制剂治疗反应的临床基因组生物标志物。
Clin Cancer Res. 2019 Oct 1;25(19):5961-5971. doi: 10.1158/1078-0432.CCR-18-4159. Epub 2019 Aug 9.
6
Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features.195例默克尔细胞癌确诊时的临床特征：AEIOU特征
J Am Acad Dermatol. 2008 Mar;58(3):375-81. doi: 10.1016/j.jaad.2007.11.020.
Zotero 插件